References
- Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med. 2010;362:823–832.
- Bosch J, García-Pagán JC. Prevention of variceal rebleeding. Lancet. 2003;361:952–4.
- Abraldes JG, Villanueva C, Bañares R, et al. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol. 2008;48:229–36.
- Ryan BM, Stockbrugger RW, Ryan JM. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology. 2004;126:1175–89.
- Tripathi D, Stanley AJ, Hayes PC, et al. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015;64:1680–1704.
- Sarin SK, Lahoti D, Saxena SP, et al. Prevalence, classification, and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology. 1992;16:1343–1349.
- Lo GH, Lai KH, Cheng JS, et al. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology. 2001;33:1060–4.
- Tan PC, Hou MC, Lin HC, et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: n-butyl-2-cyanoacrylate injection versus band ligation. Hepatology. 2006;43:690–7.
- Mishra SR, Chander SB, Kumar A, et al. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial. Gut. 2010;59:729–735.
- Kahloon A, Chalasani N, Dewitt J, et al. Endoscopic therapy with 2-octylcyanoacrylate for the treatment of gastric varices. Dig Dis Sci. 2014;59:2178–2183.
- Lo GH, Liang HL, Chen WC, et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy. 2007;39:679–85.
- Krajina A, Hulek P, Fejfar T, et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunt (TIPS). Cardiovasc Intervent Radiol. 2012;35:1295–1300.
- Mahadeva S, Bellamy MC, Kessel D, et al. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol. 2003;98:2688–2693.
- Ma J, Gong X, Luo J, et al. Impact of intrahepatic venovenous shunt on hepatic venous pressure gradient measurement. J Vasc Interv Radiol. 2020;31:2081–2088.
- Kim YJ, Raman SS, Yu NC, et al. Esophageal varices in cirrhotic patients: evaluation with liver CT. Am J Roentgenol. 2007;188:139–144.
- Huang X, Li F, Wang L, et al. Endoscopic treatment of gastroesophageal variceal bleeding after oxaliplatin-based chemotherapy in patients with colorectal cancer. Endoscopy. 2020;52:727–735.
- Garcia-Tsao G, Abraldes J G, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65:310–335.
- Hung HH, Chang CJ, Hou MC, et al. Efficacy of non-selective β-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: a randomized controlled trial. J Hepatol. 2012;56:1025–1032.
- Prachayakul V, Aswakul P, Chantarojanasiri T, et al. Factors influencing clinical outcomes of histoacryl® glue injection-treated gastric variceal hemorrhage. World J Gastroenterol. 2013;19:2379–2387.
- Mishra SR, Sharma BC, Kumar A, et al. Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial. J Hepatol. 2011;54:1161–1167.
- de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII – renewing consensus in portal hypertension. J Hepatol. 2022;76:959–974.